[Pharmacokinetics of antilipemic agents. 4. Biotransformation of the antilipemic agent ciprofibrate (2-(4-(2,2-dichlorcyclopropyl)-phenoxy)-2-methylpropionic acid)].
Oelschläger
H
H
Rothley
D
D
Schmidt
W
W
D001711:Biotransformation; D002851:Chromatography, High Pressure Liquid; D002994:Clofibrate / Q000031:analogs & derivatives*; D002995:Clofibric Acid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000378:metabolism / Q000493:pharmacokinetics; D058607:Fibric Acids; D006801:Humans; D000960:Hypolipidemic Agents / Q000008:administration & dosage / Q000378:metabolism / Q000493:pharmacokinetics*
D058607:Fibric Acids; D000960:Hypolipidemic Agents; D002995:Clofibric Acid; C019304:ciprofibrate; D002994:Clofibrate
Zur Pharmakokinetik von Lipidsenkern, 4. Mitt. Biotransformation des Lipidsenkers Ciprofibrat (2-(4-(2,2-Dichlorcyclopropyl)-phenoxy)-2-methylpropionsäure).